Ketamine Therapy

Ketamine therapy can rapidly improve mood, reduce anxiety, and ease PTSD symptoms by targeting brain pathways differently from traditional treatments - offering fast, effective relief for people with treatment-resistant mental health conditions.

Ketamine therapy helps restore balance in brain regions disrupted by prolonged stress, trauma, or mood disorders. By promoting new neural connections, it can rapidly lift mood, reduce suicidal thoughts, and restore emotional flexibility — offering a different approach when standard antidepressants have failed.

Ketamine therapy can reduce persistent pain by interrupting faulty nerve signalling and promoting healthy brain connections, offering relief for complex, treatment-resistant chronic pain conditions.

Ketamine therapy helps recalibrate the nervous system by interrupting maladaptive pain signalling and reducing central sensitisation. It can relieve neuropathic, nociplastic, and chronic widespread pain, improving physical function, reducing reliance on opioids, and restoring quality of life when conventional pain treatments have failed.

Often considered the "gold standard", intravenous (IV) infusion is the most researched form of ketamine therapy. It delivers ketamine directly into the bloodstream for more precise and reliable dosing. It can be used for treatment-resistant depression, post-traumatic stress disorder and chronic pain.

IV infusion offers a number advantages over other routes. It has tighter control of dosing and rate, allowing adjustments mid-session if needed. It has the highest bioavailability compared to all other routes. And it allows for more flexible dosing protocols.

Intramuscular (IM) and subcutaneous (SC) injections provide an alternative for patients who may not require or prefer an IV line. These routes deliver rapid relief and are well-suited to specific treatment needs.

A TGA-approved and now PBS listed option for treatment-resistant depression, esketamine nasal spray is administered under supervision in an authorised centre.

Esketamine nasal spray offers a less-invasive alternative, with rapid onset of effect, though often requiring more frequent maintenance sessions than infusions.

Esketamine nasal spray cannot be used for PTSD or chronic pain, with minimal evidence to support its use in these areas.

Oral ketamine can be prescribed in select cases, typically as a maintenance strategy following induction. It has less evidence than the other forms of ketamine therapy. It also has lower bioavailability than infusions, injections or nasal spray. 

Following referral, we begin with a comprehensive medical and psychiatric assessment, which includes completing screening tests, questionnaires, and a medical consultation. 

This ensures ketamine therapy is safe, appropriate, and tailored to your needs before creating a personalised treatment plan.

Once approved for treatment, your sessions can begin. Depending on your treatment plan, this could be in hospital or as a day case at one of our licenced treatment centres.

Your treatment will take place in a calm, supervised clinical environment. You’ll be monitored throughout and vital signs checked regularly, with your comfort and safety as our priorities.

Once your session ends, you’ll rest in our recovery area under close nursing supervision. We’ll monitor your vitals, address any side effects, and ensure you feel ready before discharge to your support person. If you are an inpatient in a hospital, you will return to the hospital ward.

Maintenance treatments, when needed, are tailored to preserve benefits, and we coordinate with your broader care team for comprehensive support. 

We provide regular follow-up medical and nursing reviews, pathology testing, and questionnaires to track your progress, monitor effectiveness and ensure safety.